In vitro and in vivo preparation evaluations of bleomycin implants and microspheres prepared with DL-poly (lactide-co-glycolide)

Drug Development and Industrial Pharmacy

Volumn 32, Issue 2, 2006, Pages 175-184

  D'Souza, R ^a   Udupa, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Anticancer activity; Bleomycin; Implants; In situ gel; Microspheres; Poly(lactide co glycolide)

Indexed keywords

BLEOMYCIN SULFATE; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODEGRADABLE IMPLANT; CANCER TRANSPLANTATION; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG FORMULATION; GEL; MOUSE; NONHUMAN; PHARMACODYNAMICS; SOLID TUMOR; SYSTEMIC CIRCULATION; TUMOR GROWTH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; FIBROSARCOMA; GELS; MICE; MICROSPHERES; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; POLYGLACTIN 910; SOLUBILITY;

EID: 33645002207     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500466064     Document Type: Article

References (21)

1. Barr, J., Woodburn, K. W., Ng, S. Y., Shen, H. R., & Heller, J. (2002). Post surgical pain management with poly(ortho esters). Adv Drug Deliv Rev., 54, 1041-1048.
2. Bodmer, D., Kissel, T., & Traechslin, E. (1992). Factors influencing the release of peptides and proteins from biodegradable depot systems. J. Control. Rel., 21, 129-138.
3. Chandrashekar, G., & Udupa, N. (1996). Biodegradable injectable implant system for long term drug delivery using poly(lactic-co-glycolic)acid copolymers. J. Pharm. Pharmacol., 48, 669-674.
4. Danckwerts, M., & Fassihi, A. (1991). Implantable controlled release drug delivery system: a review. Drug Dev Ind Pharm, 17, 1465-1502.
5. Hnatyszyn, J., Kossovsky, N., Gelman, A., & Sponsler, E. (1994). Drug delivery systems for the future. J. Parent. Sci. Technol., 48, 247-254.
6. Jain, R., Shah, H. N., Malick, W. A., & Rhodes, C. T. (1998). Controlled drug delivery by biodegradable poly(ester) devices: Different preparative approaches. Drug Dev. Ind. Pharm., 24, 703-727.
7. Jeong, B., Bae, Y. H., Lee, D. S., & Kim, S. W. (1997). Biodegradable block copolymers as injectable drug delivery systems. Nature, 388, 860-862.
8. Kamath, R., Rao, B. S. S., & Uma Devi, P. (1999). Response of a mouse fibrosarcoma to withaferin A and radiation. Pharm. Pharmacol. Commun., 5, 287-291.
9. Langer, R. (1981). New method of drug delivery. Science, 240, 1527-1533.
10. Langer, R., & Folkman, J. (1976). Polymers for the sustained release of proteins and other macromolecules. Nature, 263, 797-800.
11. Naresh, R. A., Udupa, N., & Devi, P. U. (1996). Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice. Indian J. Exp. Biol., 8, 764-772.
12. Ogawa, Y., Yasmamoto, M., Okada, H., Yashiki, T., & Shimamoto, T. (1998). A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or poly(lactic/glycolic)acid. Chemical and Pharmaceutical Bulletin, 36, 1502-1507.
13. Persad, R. (2002). Leuprorelin acetate in prostate cancer: a European update. Int J Clin Pract., 56, 389-396.
14. Ravivarapu, H. B., Moyer, K. L., & Dunn, R. L. (2000). Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. Int J Pharm., 194, 181-191.
15. Shah, N. H., Railkar, A. S., Chen, F. C., Tarantino, R., Kumar, S., Murjani, M., Palmer, D., Infeld, M. H., & Malick, A. W. (1993). A biodegradable injectable implant for delivering micro and macromolecules using poly (lactic-co-glycolic) and (PLGA) copolymers. J. Control. Rel., 27, 139-147.
16. Snah, S. S., Gha, Y., & Pitt, C. G. (1992). Poly(lactic acid-co-DL-lactic acid): diffusion or degradation controlled delivery? J. Control. Rel., 18, 261-270.
17. Shenoy, D. B., D'Souza, R. J., & Udupa, N. (2002). Poly(DL-lactide-co-glycolide) microporous microsphere based depot formulation of a peptide-like antineoplastic agent. J. Microencaps., 19, 523-535.
18. Shiu, G. K., Goehl, T. J., & Pitlick, W. H. (1979). Rapid high-performance liquid chromatographic determination of bloemycin A2 in plasma. J. Pharm. Sci., 68, 232-243.
19. Singh, U. V., Shenoy, B. D., & Udupa, N. (2001). Novel carriers in cancer chemotherapy. In Advances in Controlled and Novel Drug Delivery, Jain, N. K., Ed.; CBS Publishers: New Delhi, 40-69 .
20. Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jaaskelainen, J., & Ram, Z. (2003). A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol., 5, 79-88.
21. Zentner, G. M., Rathi, R., Shih, C., McRea, J. C., Seo, M. H., Oh, H., Rhee, B. G., Mestecky, J., Moldoveanu, Z., Morgan, M., & Weitman, S. (2001). Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. J. Control. Rel., 72, 203-215.